Inhibition of tumor growth and angiogenesis of tamoxifen‑resistant breast cancer cells by ruxolitinib, a selective JAK2 inhibitor
Ji Eun Kim(Dongguk University), Keon Wook Kang(Cancer Research Institute)
Cited by 61
Related Papers
Assessment of lymph node metastases using 18F-FDG PET in patients with advanced gastric cancer
|European Journal of Nuclear Medicine and Molecular Imaging|2005|175
Physical limits of pure superparamagnetic Fe3O4 nanoparticles for a local hyperthermia agent in nanomedicine
|Applied Physics Letters|2012|90
Induction of multidrug resistance associated protein 2 in tamoxifen-resistant breast cancer cells
|Endocrine Related Cancer|2007|87